Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252668
Status:
COMPLETED
Last Update Posted:
2011-05-18
First Post:
2005-11-09
Brief Title:
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open-Label Multicentre Extension Study of the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an open label extension of a previously completed double-blind randomized study comparing etanercept and methotrexate in subjects with active rheumatoid arthritis All subjects will receive combination treatment with etanercept and methotrexate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 0881A1-400 | None | None | None |
| B1801221 | None | None | None |